Chemical
Browse
Active Pharmaceutical Ingredients
Bioactive chemicals
Agrochemicals
Search
Chemical Structure
Explore
Chemical Similarity
Transformation
Browse
Prodrugs
Drug Metabolites
Metabolite Datasets
Cytochrome P450
Homo sapiens »
CYP1
CYP2
CYP3
CYP4
CYP5
CYP7
CYP8
CYP11
CYP17
CYP19
CYP20
CYP21
CYP24
CYP26
CYP27
CYP39
CYP46
CYP51
Mus musculus
Danio rerio
Oncorhynchus mykiss
Comparison of CYPs
Biochemical Action
Browse
Target Level (ChEMBL)
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Mechanism of action
Search
Mechanism of action
BLAST against human drug target
BLAST against selected species (UniProt)
Exposure
Browse
Monitoring data
Downloads
Web services
Bulk downloads
About
About EcoDrug+
Citing
Data Sources
FAQ
Contact Us
Versions
Display Options:
Molecule Type
Mechanism of Action
Route of Adminstration
Status
Therapeutic Indication
Number of compounds:
7959
DOLUTEGRAVIR
(2013)
Small molecule
Unknown
ORAL
Approved
Virus Diseases
DOLUTEGRAVIR
×
Maximum Phase:
4
First Approval:
2013
UNII:
DKO1W9H7M1
Molecule Type:
Small molecule
Molecular Formula:
C20H19F2N3O5
Molecular Weight:
419.38
AlogP:
1.35
PSA:
100.87
HBD:
2.0
HBA:
#RotB:
3.0
Source:
LEVOMILNACIPRAN HYDROCHLORIDE
(2013)
Small molecule
Norepinephrine transporter inhibitor
ORAL
Approved
Depressive Disorder, Major; Fibromyalgia
LEVOMILNACIPRAN HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2013
UNII:
371U2ZK31U
Molecule Type:
Small molecule
Molecular Formula:
C15H23ClN2O
Molecular Weight:
282.81
AlogP:
1.77
PSA:
46.33
HBD:
1.0
HBA:
#RotB:
5.0
Source:
UMECLIDINIUM
(2013)
Small molecule
Unknown
Unknown
Approved
Unknown
UMECLIDINIUM
×
Maximum Phase:
4
First Approval:
2013
UNII:
GE2T1418SV
Molecule Type:
Small molecule
Molecular Formula:
C29H34NO2+
Molecular Weight:
428.6
AlogP:
5.14
PSA:
29.46
HBD:
1.0
HBA:
#RotB:
8.0
Source:
OMEGA-3-CARBOXYLIC ACIDS
(2014)
Small molecule
Unknown
ORAL
Approved
Unknown
OMEGA-3-CARBOXYLIC ACIDS
×
Maximum Phase:
4
First Approval:
2014
UNII:
F85N2YHE4E
Molecule Type:
Small molecule
Molecular Formula:
C181H286O18
Molecular Weight:
2750.26
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
SUVOREXANT
(2014)
Small molecule
Orexin receptor antagonist
ORAL
Approved
Sleep Initiation and Maintenance Disorders
SUVOREXANT
×
Maximum Phase:
4
First Approval:
2014
UNII:
081L192FO9
Molecule Type:
Small molecule
Molecular Formula:
C23H23ClN6O2
Molecular Weight:
450.93
AlogP:
4.11
PSA:
80.29
HBD:
0.0
HBA:
#RotB:
3.0
Source:
FLORBETABEN F18
(2014)
Small molecule
Diagnostic agent
Unknown
Approved
Alzheimer Disease; Cognitive Dysfunction
FLORBETABEN F18
×
Maximum Phase:
4
First Approval:
2014
UNII:
TLA7312TOI
Molecule Type:
Small molecule
Molecular Formula:
C21H26FNO3
Molecular Weight:
358.44
AlogP:
4.28
PSA:
39.72
HBD:
1.0
HBA:
#RotB:
12.0
Source:
CEFTOLOZANE
(2014)
Small molecule
Unknown
Unknown
Approved
Unknown
CEFTOLOZANE
×
Maximum Phase:
4
First Approval:
2014
UNII:
37A4IES95Q
Molecule Type:
Small molecule
Molecular Formula:
C23H30N12O8S2
Molecular Weight:
666.7
AlogP:
-3.9
PSA:
302.21
HBD:
7.0
HBA:
#RotB:
12.0
Source:
PERAMIVIR
(2014)
Small molecule
Neuraminidase inhibitor
INTRAVENOUS
Approved
Influenza, Human; Virus Diseases
PERAMIVIR
×
Maximum Phase:
4
First Approval:
2014
UNII:
QW7Y7ZR15U
Molecule Type:
Small molecule
Molecular Formula:
C15H34N4O7
Molecular Weight:
382.46
AlogP:
-0.14
PSA:
148.53
HBD:
6.0
HBA:
#RotB:
7.0
Source:
DAPAGLIFLOZIN
(2014)
Small molecule
Sodium/glucose cotransporter 2 inhibitor
ORAL
Approved
Diabetes Mellitus
DAPAGLIFLOZIN
×
Maximum Phase:
4
First Approval:
2014
UNII:
1ULL0QJ8UC
Molecule Type:
Small molecule
Molecular Formula:
C21H25ClO6
Molecular Weight:
408.88
AlogP:
1.84
PSA:
99.38
HBD:
4.0
HBA:
#RotB:
6.0
Source:
IDELALISIB
(2014)
Small molecule
PI3-kinase p110-delta subunit inhibitor
ORAL
Approved
Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Non-Hodgkin; Neoplasms
IDELALISIB
×
Maximum Phase:
4
First Approval:
2014
UNII:
YG57I8T5M0
Molecule Type:
Small molecule
Molecular Formula:
C22H18FN7O
Molecular Weight:
415.43
AlogP:
3.75
PSA:
101.38
HBD:
2.0
HBA:
#RotB:
5.0
Source:
VORAPAXAR SULFATE
(2014)
Small molecule
Proteinase-activated receptor 1 antagonist
ORAL
Approved
Myocardial Infarction; Peripheral Arterial Disease; Stroke
VORAPAXAR SULFATE
×
Maximum Phase:
4
First Approval:
2014
UNII:
IN66038E6C
Molecule Type:
Small molecule
Molecular Formula:
C29H35FN2O8S
Molecular Weight:
590.67
AlogP:
5.63
PSA:
77.52
HBD:
1.0
HBA:
#RotB:
5.0
Source:
OMBITASVIR
(2014)
Small molecule
Nonstructural protein 5A inhibitor
Unknown
Approved
Hepatitis C; Hepatitis C, Chronic
OMBITASVIR
×
Maximum Phase:
4
First Approval:
2014
UNII:
2302768XJ8
Molecule Type:
Small molecule
Molecular Formula:
C50H67N7O8
Molecular Weight:
894.13
AlogP:
7.69
PSA:
178.72
HBD:
4.0
HBA:
#RotB:
13.0
Source:
EMPAGLIFLOZIN
(2014)
Small molecule
Sodium/glucose cotransporter 2 inhibitor
ORAL
Approved
Diabetes Mellitus; Diabetes Mellitus, Type 2
EMPAGLIFLOZIN
×
Maximum Phase:
4
First Approval:
2014
UNII:
HDC1R2M35U
Molecule Type:
Small molecule
Molecular Formula:
C23H27ClO7
Molecular Weight:
450.92
AlogP:
1.61
PSA:
108.61
HBD:
4.0
HBA:
#RotB:
6.0
Source:
NALOXEGOL
(2014)
Small molecule
Unknown
Unknown
Approved
Constipation
NALOXEGOL
×
Maximum Phase:
4
First Approval:
2014
UNII:
44T7335BKE
Molecule Type:
Small molecule
Molecular Formula:
C34H53NO11
Molecular Weight:
651.79
AlogP:
1.86
PSA:
126.77
HBD:
2.0
HBA:
#RotB:
24.0
Source:
TASIMELTEON
(2014)
Small molecule
Melatonin receptor agonist
ORAL
Approved
Sleep Wake Disorders; Smith-Magenis Syndrome
TASIMELTEON
×
Maximum Phase:
4
First Approval:
2014
UNII:
SHS4PU80D9
Molecule Type:
Small molecule
Molecular Formula:
C15H19NO2
Molecular Weight:
245.32
AlogP:
2.25
PSA:
38.33
HBD:
1.0
HBA:
#RotB:
4.0
Source:
SODIUM GLYCEROPHOSPHATE
(2014)
Small molecule
Unknown
Unknown
Approved
Unknown
SODIUM GLYCEROPHOSPHATE
×
Maximum Phase:
4
First Approval:
2014
UNII:
RCS9EQ01V4
Molecule Type:
Small molecule
Molecular Formula:
C3H7Na2O6P
Molecular Weight:
216.04
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
EFINACONAZOLE
(2014)
Small molecule
Lanosterol 14-alpha demethylase inhibitor
TOPICAL
Approved
Onychomycosis
EFINACONAZOLE
×
Maximum Phase:
4
First Approval:
2014
UNII:
J82SB7FXWB
Molecule Type:
Small molecule
Molecular Formula:
C18H22F2N4O
Molecular Weight:
348.4
AlogP:
2.48
PSA:
54.18
HBD:
1.0
HBA:
#RotB:
5.0
Source:
PARITAPREVIR
(2014)
Small molecule
Hepatitis C virus serine protease, NS3/NS4A inhibitor
Unknown
Approved
Hepatitis C; Hepatitis C, Chronic
PARITAPREVIR
×
Maximum Phase:
4
First Approval:
2014
UNII:
OU2YM37K86
Molecule Type:
Small molecule
Molecular Formula:
C40H43N7O7S
Molecular Weight:
765.89
AlogP:
3.64
PSA:
189.65
HBD:
3.0
HBA:
#RotB:
7.0
Source:
CERITINIB
(2014)
Small molecule
ALK tyrosine kinase receptor inhibitor
ORAL
Approved
Carcinoma, Non-Small-Cell Lung; Neoplasms
CERITINIB
×
Maximum Phase:
4
First Approval:
2014
UNII:
K418KG2GET
Molecule Type:
Small molecule
Molecular Formula:
C28H36ClN5O3S
Molecular Weight:
558.15
AlogP:
6.36
PSA:
105.24
HBD:
3.0
HBA:
#RotB:
9.0
Source:
BELINOSTAT
(2014)
Small molecule
Histone deacetylase inhibitor
INTRAVENOUS
Approved
Lymphoma, T-Cell; Lymphoma, T-Cell, Peripheral; Neoplasms
BELINOSTAT
×
Maximum Phase:
4
First Approval:
2014
UNII:
F4H96P17NZ
Molecule Type:
Small molecule
Molecular Formula:
C15H14N2O4S
Molecular Weight:
318.35
AlogP:
2.01
PSA:
95.5
HBD:
3.0
HBA:
#RotB:
5.0
Source:
TESTOSTERONE UNDECANOATE
(2014)
Small molecule
Androgen Receptor agonist
INTRAMUSCULAR; ORAL
Approved
Hypogonadism; Klinefelter Syndrome; Neoplasms; Orchitis
TESTOSTERONE UNDECANOATE
×
Maximum Phase:
4
First Approval:
2014
UNII:
H16A5VCT9C
Molecule Type:
Small molecule
Molecular Formula:
C30H48O3
Molecular Weight:
456.71
AlogP:
7.96
PSA:
43.37
HBD:
0.0
HBA:
#RotB:
10.0
Source:
LEDIPASVIR
(2014)
Small molecule
Nonstructural protein 5A inhibitor
Unknown
Approved
Hepatitis C; Hepatitis C, Chronic
LEDIPASVIR
×
Maximum Phase:
4
First Approval:
2014
UNII:
013TE6E4WV
Molecule Type:
Small molecule
Molecular Formula:
C49H54F2N8O6
Molecular Weight:
889.02
AlogP:
8.61
PSA:
174.64
HBD:
4.0
HBA:
#RotB:
10.0
Source:
FINAFLOXACIN
(2014)
Small molecule
DNA gyrase inhibitor
OTIC
Approved
Unknown
FINAFLOXACIN
×
Maximum Phase:
4
First Approval:
2014
UNII:
D26OSN9Q4R
Molecule Type:
Small molecule
Molecular Formula:
C20H19FN4O4
Molecular Weight:
398.39
AlogP:
1.22
PSA:
107.59
HBD:
2.0
HBA:
#RotB:
3.0
Source:
NETUPITANT
(2014)
Small molecule
Neurokinin 1 receptor antagonist
Unknown
Approved
Postoperative Nausea and Vomiting
NETUPITANT
×
Maximum Phase:
4
First Approval:
2014
UNII:
7732P08TIR
Molecule Type:
Small molecule
Molecular Formula:
C30H32F6N4O
Molecular Weight:
578.6
AlogP:
6.79
PSA:
39.68
HBD:
0.0
HBA:
#RotB:
5.0
Source:
DASABUVIR SODIUM
(2014)
Small molecule
Hepatitis C virus NS5B RNA-dependent RNA polymerase inhibitor
Unknown
Approved
Hepatitis C; Hepatitis C, Chronic
DASABUVIR SODIUM
×
Maximum Phase:
4
First Approval:
2014
UNII:
OG6D40M62L
Molecule Type:
Small molecule
Molecular Formula:
C26H28N3NaO6S
Molecular Weight:
533.58
AlogP:
4.02
PSA:
110.26
HBD:
2.0
HBA:
#RotB:
5.0
Source:
NINTEDANIB ESYLATE
(2014)
Small molecule
Fibroblast growth factor receptor inhibitor
Unknown
Approved
Idiopathic Pulmonary Fibrosis; Scleroderma, Systemic
NINTEDANIB ESYLATE
×
Maximum Phase:
4
First Approval:
2014
UNII:
42F62RTZ4G
Molecule Type:
Small molecule
Molecular Formula:
C33H39N5O7S
Molecular Weight:
649.77
AlogP:
3.62
PSA:
94.22
HBD:
2.0
HBA:
#RotB:
7.0
Source:
NINTEDANIB
(2014)
Small molecule
Unknown
Unknown
Approved
Idiopathic Pulmonary Fibrosis; Neoplasms
NINTEDANIB
×
Maximum Phase:
4
First Approval:
2014
UNII:
G6HRD2P839
Molecule Type:
Small molecule
Molecular Formula:
C31H33N5O4
Molecular Weight:
539.64
AlogP:
3.62
PSA:
94.22
HBD:
2.0
HBA:
#RotB:
7.0
Source:
DROXIDOPA
(2014)
Small molecule
Adrenergic receptor agonist
ORAL
Approved
Cardiovascular Diseases; Hypotension, Orthostatic; Multiple System Atrophy
DROXIDOPA
×
Maximum Phase:
4
First Approval:
2014
UNII:
J7A92W69L7
Molecule Type:
Small molecule
Molecular Formula:
C9H11NO5
Molecular Weight:
213.19
AlogP:
-0.46
PSA:
124.01
HBD:
5.0
HBA:
#RotB:
3.0
Source:
MILTEFOSINE
(2014)
Small molecule
Unknown
ORAL
Approved
Leishmaniasis; Leishmaniasis, Cutaneous; Leishmaniasis, Mucocutaneous; Leishmaniasis, Visceral; Trypanosomiasis
MILTEFOSINE
×
Maximum Phase:
4
First Approval:
2014
UNII:
53EY29W7EC
Molecule Type:
Small molecule
Molecular Formula:
C21H46NO4P
Molecular Weight:
407.58
AlogP:
5.68
PSA:
58.59
HBD:
0.0
HBA:
#RotB:
20.0
Source:
OLODATEROL
(2014)
Small molecule
Unknown
Unknown
Approved
Lung Diseases, Obstructive
OLODATEROL
×
Maximum Phase:
4
First Approval:
2014
UNII:
VD2YSN1AFD
Molecule Type:
Small molecule
Molecular Formula:
C21H26N2O5
Molecular Weight:
386.45
AlogP:
2.38
PSA:
100.05
HBD:
4.0
HBA:
#RotB:
7.0
Source:
NALOXEGOL OXALATE
(2014)
Small molecule
Mu opioid receptor antagonist
ORAL
Approved
Cancer Pain; Constipation
NALOXEGOL OXALATE
×
Maximum Phase:
4
First Approval:
2014
UNII:
65I14TNM33
Molecule Type:
Small molecule
Molecular Formula:
C36H55NO15
Molecular Weight:
741.83
AlogP:
1.86
PSA:
126.77
HBD:
2.0
HBA:
#RotB:
24.0
Source:
OLAPARIB
(2014)
Small molecule
PARP 1, 2 and 3 inhibitor
ORAL
Approved
Neoplasms; Ovarian Neoplasms
OLAPARIB
×
Maximum Phase:
4
First Approval:
2014
UNII:
WOH1JD9AR8
Molecule Type:
Small molecule
Molecular Formula:
C24H23FN4O3
Molecular Weight:
434.47
AlogP:
2.35
PSA:
86.37
HBD:
1.0
HBA:
#RotB:
4.0
Source:
FLORBETABEN
(2014)
Small molecule
Unknown
Unknown
Approved
Unknown
FLORBETABEN
×
Maximum Phase:
4
First Approval:
2014
UNII:
TLA7312TOI
Molecule Type:
Small molecule
Molecular Formula:
C21H26FNO3
Molecular Weight:
359.44
AlogP:
4.28
PSA:
39.72
HBD:
1.0
HBA:
#RotB:
12.0
Source:
FERRIC CITRATE
(2014)
Small molecule
Phosphate sequestering agent
ORAL
Approved
Unknown
FERRIC CITRATE
×
Maximum Phase:
4
First Approval:
2014
UNII:
63G354M39Z
Molecule Type:
Small molecule
Molecular Formula:
C6H7FeO8
Molecular Weight:
262.96
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
TAVABOROLE
(2014)
Small molecule
Leucine-tRNA ligase inhibitor
TOPICAL
Approved
Onychomycosis
TAVABOROLE
×
Maximum Phase:
4
First Approval:
2014
UNII:
K124A4EUQ3
Molecule Type:
Small molecule
Molecular Formula:
C7H6BFO2
Molecular Weight:
151.93
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
VORAPAXAR
(2014)
Small molecule
Unknown
Unknown
Approved
Thrombosis
VORAPAXAR
×
Maximum Phase:
4
First Approval:
2014
UNII:
ZCE93644N2
Molecule Type:
Small molecule
Molecular Formula:
C29H33FN2O4
Molecular Weight:
492.59
AlogP:
5.63
PSA:
77.52
HBD:
1.0
HBA:
#RotB:
5.0
Source:
1
2
…
63
64
65
66
67
68
69
…
221
222
Next »
Download Option
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA